Introduction
Methods
Review questions
Study inclusion criteria
Study exclusion criteria
Search strategy
Study selection
Data extraction
Assessment of methodological quality and synthesis
Instrument study selection and analysis
Content validity study selection
COSMIN analysis
Results
Study selection
Characteristics of the included studies
1st Author Publication Year | Study type | Country | Age (years) | Gender | Smoking | Sample Size | Pathology Type | Pathology(s) ICD classification | Defect type |
---|---|---|---|---|---|---|---|---|---|
De Groot 2020 | Prospective Cohort | Intervention: Canada Control: Netherlands | Intervention mean age 45.0 ± 14.3 Control mean age 70.8 ± 13.6 | Intervention: 3 Male 8 Female Control: 7 Male 6 Female | NR* | N = 24 (N = 11 Intervention: ART** = 6, Rohner = 5) (N = 13 control) | Malignant and Benign | Squamous cell carcinoma Non-SCC malignancy Benign lesions | Maxillectomy |
Pappalardo 2018 | Prospective Cohort | China and Taiwan | Intervention mean 32.3 ± 12.7 Control mean 34.7 ± 15.7 | Intervention: 13 Male 8 Female Control: 9 Male 4 Female | NR | N = 34 (N = 22 Intervention) (N = 12 control) | Benign | Ameloblastoma | Mandibulectomy |
Ciocca 2015 | Noninferiority RCT | Italy | Intervention range 29—61 Control range 34–68 | 8 Male 2 Female | NR | N = 10 (N = 5 Intervention) (N = 5 control) | Malignant | Squamous cell carcinoma | Mandibulectomy |
1st Author Publication Year | Exposure group | Implant | Prosthesis | Comparator | Follow-up Period | QoL Instrument | Radiation Therapy | Outcome Measure | Uncertainty Type | Variable | Outcome Measure Value | Uncertainty ( ±) | P value | Reported Limitations | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number | Timing | Type | Timing of Loading | Yes/No | Timing (pre/post op) | ||||||||||||
De Groot 2020 | ART: phase 1 surgery involving MFFF* with implant insertion and loading at 6 months during phase 2 Rohner: phase 1 surgery involving prefabricated fibula with implants insertion and time allowed for osseointegration and phase 2 involving MFFF harvest, reconstruction and loading at 4–6 weeks | NR | ART (during 1st phase of surgery) Rohner (during 1st phase of surgery) | Fixed and Removable | ART protocol (6 months after phase 1 surgery) Rohner protocol (4–6 weeks after phase 1) | Obturator | Exposure: mean days 914 ± 662 Control: mean days 365 ± 11 | EORTC H & N 35 | Yes for ART | NR | Mean QoL scores (low correlated with high QoL) | Standard deviation | Overall EORTC H & N 35 QoL Score Intervention Group | 13.7 | 9.2 | 0.001 | Low sample number Bias due to different surgical teams cultural differences Selection bias of dentally rehabilitated patients only |
Overall EORTC H & N 35 QoL Score Control Group | 34.5 | 9.8 | |||||||||||||||
Pappalardo 2018 | Implant supported fixed prosthesis with MFFF | Total 65 across sample, 30 osseointegrated implants primarily and 35 placed secondarily | Immediate and delayed | Fixed | 1 month following implant osseointegration | MFFF only | Total 89.1 ± 45.4 months Exposure: 100.2 ± 42.1 Control: 68.8 ± 45.8 | UW-QOL, OHIP-14 | No | NA** | Mean QoL scores (low correlated with high QoL) ± Standard Deviation | Standard deviation | Overall OHIP 14 QoL Score Intervention Group | NR | NR | < 0.05 | In exposure group one patient underwent secondary orthognathic surgery to correct malocclusion due to following-up mandible growth and three patients underwent secondary flap debulking procedures to improve facial symmetry. Two patients underwent vertical distraction osteogenesis of the fibula graft to increase bone height for dental implant placement |
Overall OHIP 14 Qol Score Control Group | NR | NR | |||||||||||||||
Overall UW-QOL Score Intervention Group | NR | NR | < 0.05 | ||||||||||||||
Overall UW-QOL Score Control Group | NR | NR | |||||||||||||||
Ciocca 2015 | Implant supported fixed prosthesis with MFFF | 8 to 4 per patient | NR | Fixed | NR | Removable prosthesis with MFFF | NR | EORTC H & N QLQ 30 | No | NA | NR | NR | Overall QoL Score Intervention Group | NR | NR | < 0.05 | Small sample size |
Overall QoL Score Control Group | NR | NR |
Effect of maxillofacial reconstruction on QoL
Instrument analysis
Validation studies
PROM Instrument Characteristics | Validation studies | PROM Instrument COSMIN Analysis | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
PROM | Original Construct | Original Target population | Original Context of use | Number of items and Subscales | Recall period | Response options | Validated Population | General PROM Development Rating | Content Validity* | Quality of Evidence for Relevance, Comprehensiveness and Comprehensibility | ||
Relevance Rating | Comprehensiveness Rating | Comprehensibility Rating | ||||||||||
EORTC H & N 35 + | HRQoL | Head and neck cancers (larynx, oral, pharynx, sinus, salivary glands) | For use in clinical trials before, during, and after in patients receiving combinations of radiotherapy, surgery, or chemotherapy | EORTC H& N 35: 35 items Subscale: · Pain · Swallowing · Senses · Saliva · Trismus · Speech · Social eating · Social contact · Sexuality · Nutrition EORTC QLQ30: 30 items Subcale: · Physical functioning · Role functioning · Cognitive functioning · Emotional functioning · Social functioning · Fatigue · Pain · Nausea and Vomiting · Global QOL | Past week | EORTC H&N 35: 4-point Likert-like and yes/no EORTC QLQ30: 4 point Likert | No content validity studies on maxillofacial reocnstruction Related content validity studies: · Carrillo 2013: Spanish translation, various HN cancers grouped, awaiting treatment[71] · Chie 2003: Taiwanese version, nasopharyngeal carcinoma, undergoing radio/chemotherapy[72] · Jensen 2006: Danish version, various HN cancers grouped, unspecified surgery[73] · Zahid 2022: Urdu version, various HN cancers grouped, unspecified surgery, undergoing radio/chemotherapy[74] | Adequate Head and neck oncology patient and expert involvement in concept elicitation, comprehensiveness and comprehensibility analysis | Overall: ± Inconsistent PROM development studies: ± Sufficient evidence for QoL however insufficient evidence for maxillofacial reconstruction as originally designed for head and neck oncology population. Insufficient evidence for context of use as intended for research applications rather than clinical Validation studies: None available for maxillofacial reconstruction Reviewers rating of PROM instrument: Some relevant items, others may be unnecessary. Unable to determine if > 85% of items are relevant for maxillofacial reconstruction | Overall: + sufficient PROM development studies: Head and neck oncology patient and experts involved in instrument comprehensiveness analysis Validation studies: None available for maxillofacial reconstruction Reviewers ratings of PROM instrument: comprehensive concept coverage, most of which likely apply to maxillofacial reconstruction, however cannot definitively conclude if all key maxillofacial reconstruction concepts are included | Overall: + Sufficient PROM development studies: Head and neck oncology patients involved in item comprehensibility analysis Validation studies: None available for maxillofacial reconstruction Reviewer ratings of PROM instrument: > 85% of the items appear to be appropriately worded | Moderate Evidence mainly from PROM development studies and reviewer ratings of instrument itself, however no content validity studies available for maxillofacial reconstruction |
EORTC H & N 43 (latest version of EORTC H&N 35) + EORTC QLQ 30 (same as above) | Same as above | Same as above | Same as above | 43 items Subscales: same as above EORTC QLQ30: 30 items Subscales: same as above | Same as above | Same as above | No content validity studies on maxillofacial reconstruction Related content validity studies: Davudov 2020: · Azerbaijan translation, oral cancer patients, resection + unspecified flap reconstruction [75, 76] · Zahid 2022: Urdu version, various HN cancers grouped, unspecified surgery, undergoing radio/chemotherapy [74] | Adequate Head and neck oncology patient and expert involvement in concept elicitation, comprehensiveness and comprehensibility analysis | Overall: ± Inconsistent PROM development studies: Sufficient evidence for QoL however insufficient evidence for maxillofacial reconstruction as originally designed for head and neck oncology population. Insufficient evidence for context of use as intended for research applications rather than clinical Validation studies: None available for maxillofacial reconstruction Reviewers rating of PROM instrument: Some relevant items, others may be unnecessary. Unable to determine if > 85% of items are relevant for maxillofacial reconstruction | Overall: + sufficient PROM development studies: Head and neck oncology patient and experts involved in concept and item generation Validation studies: None available for maxillofacial reconstruction Reviewers ratings of PROM instrument: comprehensive concept coverage, most of which likely apply to maxillofacial reconstruction, however cannot definitively conclude if all key maxillofacial reconstruction concepts are included | Overall: + Sufficient PROM development studies: Head and neck oncology patients involved in item comprehensibility analysis Validation studies: None available for maxillofacial reconstruction Reviewer ratings of PROM instrument: > 85% of the items appear to be appropriately worded | Moderate Evidence mainly from PROM development studies and reviewer ratings of instrument itself, however no content validity studies available for maxillofacial reconstruction |
HRQoL | Head and neck cancer patients in all stages and with varied tumor sites | For use in broad group of head and neck cancer patients to provide a standardised basis for comparison of treatment outcomes across tumour sites and stages | 17 items: Subscales: · Pain · Appearance · Activity · Recreation · Swallowing · Chewing · Speech · Shoulder · Taste · Saliva · Mood · Anxiety · Global QOL items · Other issues in free text | Past week | Range from 0 for worst to 100 for best and written responses | No content validity studies on maxillofacial reoconstruction Related content validity studies: · Lee 2017: 36 of 211 patients had tumour resection, lymph node dissection and reconstruction with free flap, others had resection only ± lymph node dissection ± radio/chemotherapy[79] · Adnane 2016: Moroccan translation, unspecified surgery ± radio/chemotherapy, various HN cancers grouped[80] · Katre 2008: Appearance domain, oropharyngeal carcinoma, unspecified surgery[81] · Rogers 1998: 25 of 29 had unspecified free flap following resection of oral cancer ± adjuvant radiotherapy[82] · Rogers 2010: Physical and social-emotional subscale validation, 291 of 838 patients had unspecified free flap surgery for oral/oropharyngeal cancers ± radio/chemotherapy[83] · Thomas 2009: Speech domain, various HN cancers grouped, unspecified free flap in 48 of 77 patients[84] · Thomas 2008: swallow domain, various HN cancers, unspecified free flap in 48 of 77 patients[85] · Zuydam 2012: Swallow domain, oral and oropharyngeal carcinoma, 68 of 94 patients had unspecified free flap surgery[86] · D’cruz 2007: Marathi and Hindi versions, various HN cancer patients[87] · Nazar 2010: Spanish translation, various HN cancers, unspecified surgery, radiation, chemotherapy[88] · Senkal 2012: Turkish translation, various HN cancers, unspecified surgery, radiation, chemotherapy[89] · Vartanian 2006: Brazilian–Portuguese translation, various HN cancers, unspecified surgery, radiation, chemotherapy [90] | Doubtful Patient or expert involvement in concept elicitation, comprehensiveness and patient comprehensibility analysis of items not specified during PROM development | Overall: ± Inconsistent PROM development studies: Sufficient evidence for QoL and possibly for context of use however insufficient evidence for maxillofacial reconstruction as originally designed for head and neck oncology population Validation studies: None available for maxillofacial reconstruction Reviewers rating of PROM instrument: > 85% of items appear relevant for maxillofacial reconstruction | Overall: ± inconsistent PROM development studies: patient or expert involvement in concept generation for comprehensiveness analysis not specified Validation studies: None available for maxillofacial reconstruction Reviewers rating of PROM instrument: Although items appear to cover some concept subscales for maxillofacial reconstruction, instrument lacks potentially key subscales such as nutrition, social impact etc | Overall: ± Inconsistent PROM development studies patient involvement in comprehensibility analysis of items not specified Validation studies: None available for maxillofacial reconstruction Reviewers rating of PROM instrument: > 85% of the items appear to be appropriately worded | Low Evidence mainly from reviewer ratings of instrument itself, as no content validity studies available for maxillofacial reconstruction and PROM development studies being of doubtful quality | |
Oral Health Impact Profile – 14 (OHIP 14)[91] | OHRQoL | Dentate and edentulous patients | Designed to measure patient's perception of the social impact of oral disorders on their well-being | 14 items Subscales: · Functional limitation · Physical pain · Psychological discomfort · Physical disability · Psychological disability · Social disability · Handicap | Past year | 5-point Likert | No content validity studies on maxillofacial reconstruction Related content validity studies: · Tesic 2020: Various HN cancers grouped, unspecified surgery ± radio/chemotherapy[92] · Edentulous patients, dentures and implant supported prosthesis grouped [93] | Doubtful Patient involvement in item reduction. Otherwise, patient or expert involvement in concept elicitation, comprehensiveness and patient comprehensibility analysis of items not specified during PROM development | Overall: ± Inconsistent PROM development studies: Sufficient evidence for QoL however insufficient evidence for maxillofacial reconstruction as originally designed for target population of dentate and edentulous individuals Validation studies: None available for maxillofacial reconstruction Reviewers rating of PROM instrument: > 85% of items appear relevant for maxillofacial reconstruction | Overall: ± Inconsistent PROM development studies: patient or expert involvement in concept or item generation not specified Validation studies: None available for maxillofacial reconstruction Reviewers rating of PROM instrument: Although items appear to cover some concept subscales for maxillofacial reconstruction, instrument lacks potentially key subscales such as speech, swallowing etc | Overall: ± Inconsistent PROM development studies: patient involvement in comprehensibility analysis of items not specified Validation studies: None available for maxillofacial reconstruction Reviewers rating of PROM instrument: > 85% of the items appear to be appropriately worded | Low Evidence mainly from reviewer ratings of instrument itself, as no content validity studies available for maxillofacial reconstruction and PROM development studies being of doubtful quality |